Big Health Company Market Research Report

Company Overview

• Name: Big Health

• Mission: To help millions back to good mental health by providing digital treatments and programs for the most common mental health conditions, including insomnia, anxiety, and depression.

• Founded By: Peter Hames and Dr. Colin Espie

• Headquarters: No information is available

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Developing digital mental health treatments, including Sleepio and Daylight, that are innovative and based on cognitive behavioral therapy (CBT).

Products

Sleepio

• Description: Sleepio is a digital program aimed at improving sleep using techniques rooted in cognitive behavioral therapy for insomnia (CBT-I). It is designed to help users develop better sleep habits and is accessible anytime.

• Key Features:

• Provides customized sleep education and support.

• Offers progress tracking with a detailed sleep diary.

• Delivers content through interactive and evidence-based digital therapy.

Daylight

• Description: Daylight is a digital program designed to help individuals manage and reduce anxiety. It uses cognitive behavioral therapy techniques to guide users to better manage their anxiety symptoms.

• Key Features:

• Evidence-based techniques for managing anxiety.

• Immediate access anytime, with no waitlists.

• Interactive and personalized guidance to support emotional well-being.

Spark Direct

• Description: Spark Direct is an evidence-based digital program for adolescents aged 13+ designed to reduce symptoms of depression and enhance emotional well-being.

• Key Features:

• Built on behavioral activation principles.

• Includes mood tracking with built-in safety features.

• Structured as a five-week self-paced program with interactive exercises.

DaylightRx

• Description: DaylightRx is a digitally delivered treatment for generalized anxiety disorder (GAD) that has been cleared by the FDA. It employs CBT techniques to help improve anxiety symptoms and is available on prescription.

• Key Features:

• A 90-day treatment platform focusing on anxiety reduction techniques.

• Includes guided exercises like stimulus control and cognitive restructuring.

• Designed as an accessible, non-medication alternative to treat GAD.

Recent Developments

• FDA Clearances: DaylightRx received FDA clearance as the first non-drug treatment for generalized anxiety disorder. SleepioRx was also cleared for treating insomnia disorder.

• Product Launches: As of the recent developments, DaylightRx has been launched, expanding Big Health's offering of regulatory-cleared digital mental health solutions.

• Leadership Changes: Yael Berman appointed as new CEO to lead Big Health's next phase of growth.

• Strategic Acquisitions: Acquired Limbix to expand into adolescent mental health care, continuing their mission to address the youth mental health crisis.

• Research and Validation: Ongoing commitment to evidence-based approaches is emphasized by numerous peer-reviewed publications and randomized controlled trials demonstrating the efficacy of Sleepio, Daylight, and Spark Direct.

Additional Information

• Big Health partners with employers, health plans, and international health systems to provide scalable and inclusive mental health solutions.

• The company has been successful in reducing healthcare costs significantly, evidenced by decreased emergency department visits and medication claim costs.

• Big Health's digital mental health programs have not been reviewed or approved by the FDA but have shown effectiveness in independent studies and clinical trials.

The information above is based on available reports and news articles concerning Big Health's market position and recent initiatives. The company is at the forefront of using digital platforms to enhance mental health care accessibility and showing a clear impact on the well-being of its users through innovative technological applications.